| Effect of resistance exercise plus cholecalciferol on nutritional status indicators in adults with Stage 4 chronic kidney disease | ||||
| Author, year | Olvera‐Soto et al., 2019 68 | Duration of intervention | 12 weeks | |
|
Participants CKD stage Age (years) |
CKD—non‐dialysis Stage 4 48 (36–52) I: 26 C: 13 |
Sarcopenia outcomes | ||
| Muscle mass | Muscle strength | Physical performance | ||
|
Between groups: %∆ SMM by BIA (NS) Within group (intervention): ↑SMM by BIA (NS) |
Between groups: %∆ Grip strength (right hand)* %∆ Grip strength (left hand)* Within group (intervention): ↑Grip strength (right hand)*** ↑Grip strength (left hand)** |
NA | ||
| Intervention description | ||||
|
I: Intervention group: resistance training 60 min ×3/week + daily oral cholecalciferol supplementation. Resistance exercise programme; start: 15 min warm‐up period, next: light or medium resistance bands used to perform each of the 6 exercises with 8 repetitions of each: scapular retraction, scapular protraction, scapular depression with shoulder abduction, elbow flexion, shoulder abduction, sit‐ups. Record keeping: patients received training to fill a log to report days, duration, and intensity of exercise sessions. Cholecalciferol intake: dosing scheme according to serum levels: serum concentration >20 ng/dL; supplement with 600 IU cholecalciferol/day, serum concentration 10–19.9 ng/dL; supplement with 1600 IU cholecalciferol/day, serum concentration <10 ng/dL; supplement with 7200 IU cholecalciferol/day. Record keeping: patients received training to fill a log to report days, frequency, and dosage of cholecalciferol intake. Control group: standard medical care without participation in exercise programme. | ||||
| Effect of oral nutritional supplementation with and without exercise on nutritional status and physical function of adult haemodialysis patients: a parallel controlled clinical trial (AVANTE‐HEMO Study) | ||||
| Author, year | Martin‐Alemany et al., 2019 72 | Duration of intervention | 12 weeks | |
|
Participants CKD stage Age (years) |
ESRD on haemodialysis (2×/week) 29 ± 9.3 (1) ONS: 13 (2) ONS + RE: 9 (3) ONS + AE: 12 |
Sarcopenia outcomes | ||
| Muscle mass | Muscle strength | Physical performance | ||
| NA |
Within group (ONS): ↑Grip strength* ↑STS (NS) Within group (ONS + RE): ↑Grip strength* ↑STS* Within group (ONS + AE): ↑Grip strength* ↑STS* Effect size (Cohen's d): Grip strength ONS + RE (1.01) ONS + AE (0.60) ONS (0.11) STS ONS + RE (0.81) ONS + AE (1.20) ONS (0.52) |
Within group (ONS): ↓TUG* ↑6MWT* Within group (ONS + RE): ↓TUG* ↑6MWT* Within group (ONS + AE): ↓TUG* ↑6MWT* Effect size (Cohen's d): TUG ONS + RE (1.04) ONS + AE (1.6) ONS (0.91) 6MWT ONS + RE (0.94) ONS + AE (1.11) ONS (0.35) |
||
| Intervention description | ||||
|
All patients were provided with a 35 kcal/kg diet plan adjusted for age, sex, and physical activity and consists of: 1.2 g protein/kg, 25–35% fat, and 50–60% carbohydrates as percentages of the total energy requirement. Oral nutritional supplementation group (ONS): during haemodialysis sessions ×2/week
ONS plus aerobic exercise group (ONS + AE): during haemodialysis sessions ×2/week
ONS plus resistance exercise group (ONS + RE): during haemodialysis sessions ×2/week
Both exercise groups:
| ||||
| The effect of resistance exercise to augment long‐term benefits of intradialytic oral nutritional supplementation in chronic haemodialysis patients | ||||
| Author, year | Dong et al., 2011 69 | Duration of intervention | 6 months | |
|
Participants CKD stage Age (years) |
ESRD on haemodialysis 43 ± 13
|
Sarcopenia outcomes | ||
| Muscle mass | Muscle strength | Physical performance | ||
|
Between groups at 3, 6 months: ∆ SMM (kg) by DXA (NS) ∆ ASMM (kg) by DXA (NS) |
NA | NA | ||
| Intervention description | ||||
|
ONS group:
ONS + RE group: ONS Received same intervention as ONS only group.
RE
| ||||
| The effects of high‐load strength training with protein‐containing or non‐protein‐containing nutritional supplementation in patients undergoing dialysis | ||||
| Author, year | Molsted et al., 2013 70 | Duration of intervention | 16 weeks | |
|
Participants CKD stage Age (years) |
ESRD on haemodialysis and peritoneal dialysis 55 ± 14 E + PRO: 16 E + Non‐PRO: 13 |
Sarcopenia outcomes | ||
| Muscle mass | Muscle strength | Physical performance | ||
| NA |
All participants: ↑STS*** (between control period and training period) Diff between the two groups: STS (NS) |
NA | ||
| Intervention description | ||||
|
Participants were recruited to a control period of 16 weeks with no intervention followed by an intervention period of 16 weeks with strength training. Progressive high‐load strength training in both groups
Supplementations in both groups:
PRO group: Provided with protein supplementation of 125 mL containing 9.4 g protein (100% whey, 14.3% leucine), 25 g carbohydrate, and 12.5 g lipid (250 kcal). The non‐PRO group: Provided with energy supply of 54.5 mL containing 2.4 g carbohydrate and 27.3 g lipid (250 kcal). | ||||
| The effects of resistance exercise and oral nutritional supplementation during haemodialysis on indicators of nutritional status and quality of life | ||||
| Author, year | Martin‐Alemañy et al., 2016 71 | Duration of intervention | 3 months | |
|
Participants CKD stage Age (years) |
ESRD on haemodialysis (2×/week) 34 (24.5–43) ONS plus RE: 17 Control ONS: 19 |
Sarcopenia outcomes | ||
| Muscle mass | Muscle strength | Physical performance | ||
| NA |
Within group (ONS): ↑Grip strength* Within Group (ONS + RE): ↑Grip strength* |
NA | ||
| Intervention description | ||||
|
ONS both groups Consisted of 434 kcal, 19.2 g protein and 22.8 g lipids, low in vitamins A and D and high in folates and vitamin B6, with high‐oleic safflower oil, corn syrup solids, and fructooligosaccharides (FOSs). ONS plus RE
ONS
RE
Control group (ONS) During haemodialysis sessions, patients received a can of a specialized ONS for maintenance dialysis patients | ||||
Data shown as mean ± SD or median (range). 1‐RM, one repetition maximum; 6MWT, 6 min walking test; AE, aerobic exercise; ASMM, appendicular skeletal muscle mass; C, control; CKD, chronic kidney disease; DXA, dual‐energy absorptiometry; E, exercise; I, intervention; NA, not available; ONS, oral nutritional supplementation; RE, resistance exercise; RPE, rated perceived exertion; SMM, skeletal muscle mass; STS, sit‐to‐stand test; TUG, timed‐up‐and‐go test.
∆, change; %∆, per cent change; ↑, increase; ↓, decrease; ↔, no change. NS, not significant.
P < 0.05.
P < 0.01.
P < 0.001.